|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.95 SEK | +3.33% |
|
+16.25% | +75.47% |
| Apr. 25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Jan. 29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Arcoma AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 37.59 million compared to SEK 24.29 million a year ago. Revenue was SEK 37.94 million compared to SEK 24.37 million a year ago.
Net loss was SEK 2.34 million compared to SEK 1.21 million a year ago. Basic loss per share from continuing operations was SEK 0.18 compared to SEK 0.09 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +75.47% | 16.24M | |
| -5.77% | 14.6B | |
| -40.71% | 2.71B | |
| -12.92% | 2.44B | |
| -8.78% | 1.51B | |
| -.--% | 1.12B | |
| +40.66% | 518M | |
| +10.95% | 239M | |
| +1.67% | 183M | |
| -.--% | 168M |
ARCOMA AB 
